QL
CNTA

Quarry LP’s Centessa Pharmaceuticals CNTA Stock Holding History

Quarry LP’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,999
Closed -$118K – 2220
2025
Q2 		$118K Buy
+8,999
New +$114K 0.03% 491
2024
Q3 		– Sell
-9,608
Closed -$86.8K – 1709
2024
Q2 		$86.8K Buy
9,608
+3,108
+48% +$29.5K 0.03% 403
2024
Q1 		$73.5K Buy
6,500
+500
+8% +$4.74K 0.01% 310
2023
Q4 		$47.8K Buy
+6,000
New +$40.2K 0.01% 347

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Quarry LP's CNTA Position: Q3 2025 in Review

Quarry LP sold out of Centessa Pharmaceuticals (CNTA) in Q3 2025, closing a stake of 8,999 shares — an estimated $118K sold.

Quarry LP first reported a position in CNTA in Q4 2023 and held it in 4 quarters. The position peaked at $118K in Q2 2025. 125 funds tracked by Wall St. Rank hold CNTA as of Q3 2025.

  • Quarry LP reported no remaining Centessa Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Quarry LP sold 8,999 Centessa Pharmaceuticals shares in Q3 2025, an estimated $118K.
  • Quarry LP first reported a position in Centessa Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Quarry LP's Centessa Pharmaceuticals position peaked at $118K in Q2 2025.
  • 125 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q3 2025.

Based on Quarry LP's 13F filing for Q3 2025, filed 14 Nov 2025.